Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN
 

Drug Discovery

Covid-19

4′-Fluorouridine fights respiratory viruses, including SARS-CoV-2, in animals

If effective in humans, the oral antiviral could be dosed less frequently than antivirals currently seeking regulatory approval

by Bethany Halford
December 9, 2021

Article:

This article has been sent to the following recipient: